Insider Trading24 Sept 2026, 10:09 pm
Titan Biotech Closes Trading Window for Insider Trading
AI Summary
Titan Biotech Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015 and the company's internal code of conduct. The window will be shut from October 01, 2026, until 48 hours after the declaration of the company's unaudited financial results for the quarter and half-year ending September 30, 2026. This measure is to prevent potential insider trading activities around the announcement of financial results. The specific date for the board meeting to approve these results will be communicated later.
Key Highlights
- Trading window closed from October 1, 2026.
- Closure is due to upcoming financial results announcement.
- Aims to prevent insider trading activities.
- Applies to designated persons and connected individuals.
- Specific board meeting date for results to be announced.
Price Impact
More from TITANBIO